Announcements Trials
Browse Landscape

Phase

Phase 2 120Phase 3 55Phase 1 32Phase 1/2 31Phase 2/3 10Phase 4 6Phase EARLY_PHASE1 4Phase NA 2

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1Genitourinary 1

Conditions

Prostatic Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1

Interventions

Standard of Care 172Blood Specimen Collection 133Exercise 121Educational Status 113Methods 107Surveys and Questionnaires 104Practice Guidelines as Topic 104Interviews as Topic 103Early Intervention, Educational 92Magnetic Resonance Spectroscopy 79Specimen Handling 74Radiosurgery 67Radiotherapy 56Palliative Care 48Biopsy 40Patient Navigation 37Control Groups 35Drug Therapy 32Therapeutics 31Resistance Training 31Surgical Procedures, Operative 30Diet Therapy 30Behavior Therapy 29Counseling 28Proton Therapy 25Acupuncture Therapy 25Exercise Test 24Nutrition Assessment 23Magnetic Resonance Imaging 23Radiation 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Prednisone × 1 year × Clear all
NCT01829958 2026-05-06

Comprehensive Geriatric Assessment to Predict Toxic Events in Older Patients With Non-Hodgkin Lymphoma With Imbedded Pilot Study of Pre-Phase Therapy

Memorial Sloan Kettering Cancer Center

Phase NA Active not recruiting
201 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT01961843 2025-11-25

Abiraterone Acetate for Castrate Resistant Prostate Cancer

Massachusetts General Hospital

Phase NA Completed
40 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡